Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers

Cell chemical biology(2023)10.1016/j.chembiol.2023.11.007Source: DataRank Database

Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers is a research paper published in Cell chemical biology (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus dbgap

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.24)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Alessandro Vasciaveo ORCID,Jonnell C. Small ORCID,Arie Zask ORCID,Eduard Reznik ORCID,Nailah Smith ORCID

Live enrichment

PubMed:38061356 PMC:PMC11031350 OpenAlex:https://openalex.org/W4389381964

U.S. Department of Defense

Grant: W81XWH19-1-0337

National Cancer Institute

Grant: U01CA272610

National Cancer Institute

Grant: U01CA217858

NCI NIH HHS

Grant: P01 CA087497

NIH HHS

Grant: S10 OD021764

NIH HHS

Grant: S10 OD032433

NCI NIH HHS

Grant: R35 CA197745

NIH HHS

Grant: S10 OD012351

NCI NIH HHS

Grant: U54 CA209997

NCI NIH HHS

Grant: R35 CA209896

St. Baldrick's Foundation

FWCI

1.24

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11031350/pdf/nihms-1947166.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2451945623004221?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451945623004221?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11031350

Fields of Study

Neuroblastoma Research and TreatmentsSignaling Pathways in DiseaseUbiquitin and proteasome pathwaysHumansCell Line, TumorGene Expression Regulation, NeoplasticN-Myc Proto-Oncogene ProteinNeuroblastomaNuclear ProteinsOncogene ProteinsTranscription Factors

MeSH Terms

N-Myc Proto-Oncogene ProteinHumansNeuroblastomaNuclear ProteinsTranscription FactorsOncogene ProteinsGene Expression Regulation, NeoplasticCell Line, Tumor

Keywords

NeuroblastomaDrug discoveryCell cultureCancer researchSmall moleculeTranscription factorBiologyPrenylationKinaseComputational biologyPhenotypic screeningChemistryCell biologyGeneBioinformaticsGeneticsBiochemistryPhenotypeIsoflavonoidCk2PomiferinViperMycnCasein Kinase 2PlateseqIsopomiferin

Sustainable Development Goals

SDG 0: Good health and well-being